Hot spots of retroviral integration in human CD34+ hematopoietic cells

Blood

Volumn 110, Issue 6, 2007, Pages 1770-1778

  Cattoglio, Claudia ^a   Facchini, Giulia ^b   Sartori, Daniela ^a   Antonelli, Antonella ^c   Miccio, Annarita ^c   Cassani, Barbara ^c   Schmidt, Manfred ^d   Von Kalle, Christof ^d   Howe, Steve ^e   Thrasher, Adrian J ^e   Aiuti, Alessandro ^c   Ferrari, Giuliana ^c,f   Recchia, Alessandra ^b   Mavilio, Fulvio ^b  

^a ISTITUTO ITALIANO DI TECNOLOGIA   (Italy)

^b UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^c SAN RAFFAELE SCIENTIFIC INSTITUTE   (Italy)

^d GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^e UNIVERSITY COLLEGE LONDON   (United Kingdom)

^f VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CD34 SELECTION; CONTROLLED STUDY; GENE EXPRESSION; GENE THERAPY; GENOME; GENOTOXICITY; HELA CELL; HEMATOPOIESIS; HEMATOPOIETIC CELL; HUMAN; HUMAN CELL; IMMUNE SYSTEM; LENTIVIRINAE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTO ONCOGENE; RETROVIRUS; VIRUS DNA CELL DNA INTERACTION;

EID: 34547657665     PISSN: 00064971     EISSN: 00064971     Source Type: Journal    
DOI: 10.1182/blood-2007-01-068759     Document Type: Article

References (36)

1. Hacein-Bey-Abina S, Le Deist F, Carlier F, et al. Sustained correction of X-linked severe combined immunodeficiency by ex vivo gene therapy. N Engl J Med. 2002;346:1185-1193.
2. Aiuti A, Slavin S, Aker M, et al. Correction of ADA-SCID by stem cell gene therapy combined with nonmyeloablative conditioning. Science. 2002;296:2410-2413.
3. Gaspar HB, Parsley KL, Howe S, et al. Gene therapy of X-linked severe combined immunodeficiency by use of a pseudotyped gammaretroviral vector. Lancet. 2004;364:2181-2187.
4. Ott MG, Schmidt M, Schwarzwaelder K, et al. Correction of X-linked chronic granulomatous disease by gene therapy, augmented by insertional activation of MDS1-EVI1, PRDM16 or SETBP1. Nat Med. 2006;12:401-409.
5. Baum C, Dullmann J, Li Z, et al. Side effects of retroviral gene transfer into hematopoietic stem cells. Blood. 2003;101:2099-2114.
6. Baum C, Kustikova O, Modlich U, Li Z, Fehse B. Mutagenesis and oncogenesis by chromosomal insertion of gene transfer vectors. Hum Gene Ther. 2006;17:253-263.
7. Nienhuis AW, Dunbar CE, Sorrentino BP. Genotoxicity of retroviral integration in hematopoietic cells. Mol Ther. 2006;13:1031-1049.
8. Bushman F, Lewinski M, Ciuffi A, et al. Genomewide analysis of retroviral DNA integration. Nat Rev Microbiol. 2005;3:848-858.
9. Recchia A, Bonini C, Magnani Z, et al. Retroviral vector integration deregulates gene expression but has no consequence on the biology and function of transplanted T cells. Proc Natl Acad Sci U S A. 2006;103:1457-1462.
10. Fischer A, Cavazzana-Calvo M. Integration of retroviruses: a fine balance between efficiency and danger. PLoS Med. 2005;2:e10.
11. Wu X, Luke BT, Burgess SM. Redefining the common insertion site. Virology. 2006;344:292-295.
12. Kustikova O, Fehse B, Modlich U, et al. Clonal dominance of hematopoietic stem cells triggered by retroviral gene marking. Science. 2005;308:1171-1174.
13. Calmels B, Ferguson C, Laukkanen MO, et al. Recurrent retroviral vector integration at the Mds1/Evi1 locus in nonhuman primate hematopoietic cells. Blood. 2005;106:2530-2533.
14. Testa A, Lotti F, Cairns L, et al. Deletion of a negatively acting sequence in a chimeric GATA-1 enhancer-long terminal repeat greatly increases retrovirally mediated erythroid expression. J Biol Chem. 2004;279:10523-10531.
15. Follenzi A, Sabatino G, Lombardo A, Boccaccio C, Naldini L. Efficient gene delivery and targeted expression to hepatocytes in vivo by improved lentiviral vectors. Hum Gene Ther. 2002;13:243-260.
16. Zufferey R, Donello JE, Trono D, Hope TJ. Woodchuck hepatitis virus posttranscriptional regulatory element enhances expression of transgenes delivered by retroviral vectors. J Virol. 1999;73:2886-2892.
17. Dull T, Zufferey R, Kelly M, et al. A third-generation lentivirus vector with a conditional packaging system. J Virol. 1998;72:8463-8471.
18. Schmidt M, Hoffmann G, Wissler M, et al. Detection and direct genomic sequencing of multiple rare unknown flanking DNA in highly complex samples. Hum Gene Ther. 2001;12:743-749.
19. Schmidt M, Zickler P, Hoffmann G, et al. Polyclonal long-term repopulating stem cell clones in a primate model. Blood. 2002;100:2737-2743.
20. Suzuki T, Shen H, Akagi K, et al. New genes involved in cancer identified by retroviral tagging. Nat Genet. 2002;32:166-174.
21. Hosack DA, Dennis G Jr, Sherman BT, Lane HC, Lempicki RA. Identifying biological themes within lists of genes with EASE. Genome Biol. 2003;4:R70.
22. Dennis G, Sherman BT, Hosack DA, et al. DAVID: database for annotation, visualization, and integrated discovery. Genome Biol. 2003;4:P3.
23. Mouse Retrovirus Tagged Cancer Gene Database. Available at: http://rtcgd.ncifcrf.gov. Accessed January 2007.
24. University of New South Wales. UNSW Embryology DNA-Tumor Suppressor and Oncogene Database. Available at: http://embryology.med.unsw.edu.au. Accessed January 2007.
25. Tumor Gene Database. Available at: http://www.tumor-gene.org. Accessed January 2007.
26. Hematti P, Hong BK, Ferguson C, et al. Distinct genomic integration of MLV and SIV vectors in primate hematopoietic stem and progenitor cells. PLoS Biol. 2004;2:e423.
27. Wu X, Li Y, Crise B, Burgess SM. Transcription start regions in the human genome are favored targets for MLV integration. Science. 2003;300:1749-1751.
28. Schroder AR, Shinn P, Chen H, Berry C, Ecker JR, Bushman F. HIV-1 integration in the human genome favors active genes and local hotspots. Cell. 2002;110:521-529.
29. Ashburner M, Ball CA, Blake JA, et al. Gene ontology: tool for the unification of biology: the Gene Ontology Consortium. Nat Genet. 2000;25:25-29.
30. Kalpana GV, Marmon S, Wang W, Crabtree GR, Goff SP. Binding and stimulation of HIV-1 integrase by a human homolog of yeast transcription factor SNF5. Science. 1994;266:2002-2006.
31. Mulder LC, Chakrabarti LA, Muesing MA. Interaction of HIV-1 integrase with DNA repair protein hRad18. J Biol Chem. 2002;277:27489-27493.
32. Farnet CM, Bushman FD. HIV-1 cDNA integration: requirement of HMG I(Y) protein for function of preintegration complexes in vitro. Cell. 1997;88:483-492.
33. Violot S, Hong SS, Rakotobe D, et al. The human polycomb group EED protein interacts with the integrase of human immunodeficiency virus type 1. J Virol. 2003;77:12507-12522.
34. Llano M, Vanegas M, Fregoso O, et al. LEDGF/p75 determines cellular trafficking of diverse lentiviral but not murine oncoretroviral integrase proteins and is a component of functional lentiviral preintegration complexes. J Virol. 2004;78:9524-9537.
35. Ciuffi A, Llano M, Poeschla E, et al. A role for LEDGF/p75 in targeting HIV DNA integration. Nat Med. 2005;11:1287-1289.
36. Kustikova OS, Geiger H, Li Z, et al. Retroviral vector insertion sites associated with dominant hematopoietic clones mark "stemness" pathways. Blood. 2007;109:1897-1907.